Zola Finance Inc., a 10% Holder, disposed of 694,864 Common Shares on a direct ownership basis at a price of $16.550 through a prospectus or prospectus exempt offering on December 4th, 2017. This represents a $11,499,999 divestment of the company's shares and an account share holdings change of -4.6%.
In addition, Rayray Investments Inc., a 10% Holder, disposed of 634,441 Common Shares on a direct ownership basis. This represents a $10,499,999 divestment of the company's shares and an account share holdings change of -5.2%. Stephen Arbib, also a 10% Holder, disposed of 181,269 Common Shares on a control or direction basis for registered holder MENA Investment Network Inc. This represents a $3,000,002 divestment of the company's shares and an account share holdings change of -1.7%.
MedReleaf is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
MedReleaf Corp is a Canada-based company which operates as a licensed producer of cannabis-based pharmaceutical products. The Company produces and sells its dried cannabis and cannabis oil products, including cannabis oil capsules. The Company produce an aggregate of up to 6,000 kilograms of dried cannabis and up to 1,760 kilograms of cannabis oil, and to sell and distribute within Canada an aggregate of up to 5,000 kilograms of dried cannabis, up to 1,319 kilograms of bottled cannabis oil, and up to 440 kilograms of encapsulated cannabis oil. The Company is an analytically-driven organization focused on patient care, scientific innovation, and advancing the understanding of the therapeutic benefits of cannabis.
No Comments